TSX closed
Loading markets…

Advertisement

Stocks

What's Going On With Extendicare Inc Stock Thursday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:EXE.TO

Get EXE alerts:

Photos provided by Pexels

Extendicare Inc's stock has seen a notable decline in recent trading sessions, raising questions among investors.

Extendicare Inc (EXE.TO) has experienced a downturn in its stock price this week, closing at C$36.40 on Thursday, down 4.43% for the day and 1.69% over the past week. Despite this recent pullback, the stock has shown remarkable growth year-to-date, rising 74.10%. Investors may be looking for clues about what is driving this volatility amidst significant corporate activity.

Investor takeaway: While the recent decline in Extendicare's stock price may be concerning, the company's strong year-to-date performance and ongoing initiatives in the health care sector suggest a complex but potentially rewarding investment landscape.

Advertisement

KOHO

Earn cash back with a smarter spending account

Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.

Extendicare Inc

EXE.TO

Full stock page →

EXE.TO

Extendicare Inc

Source:WealthAwesomeWealthAwesome
$12.81 (53.62%)
120 day period
$23.75$31.27$38.79Feb 4May 5Jul 29

Market cap

$3.62B

P/E

28.2x

Div. yield

1.32%

Div. / share

$0.51

52W high

$39.14

52W low

$11.86

1W change

-1.69%

Beta

1.15

Analyst Price Targets

Based on analyst covering EXE

📈

Wall Street analysts forecast EXE stock price to rise 5.8% over the next 12 months.

Consensus

Moderately Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$38.83

+5.8% Upside

Current Price

C$36.70

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on EXE's historical volatility

HistoricalForecast68%95%
C$24.64C$32.52C$40.40C$48.28C$56.17C$64.05TodayMar 23May 27Jul 29Sep 10Oct 24Dec 6

30-Day Vol

29.2%

Annualized

90-Day Vol

33.7%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$43.88

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$38.95C$35.22C$43.08
60 trading daysC$41.34C$35.85C$47.67
90 trading daysC$43.88C$36.85C$52.23

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

C$36.40: Extendicare's Latest Close, Down 4.43% Today

With a 52-week range of C$11.86 to C$39.14, Extendicare's current price is near the upper end, reflecting strong year-to-date gains but also potential for profit-taking.

Bull case

The health care sector is growing, especially in home health care, where Extendicare is focusing its efforts. The company's recent financial results show strong operational performance, with significant increases in adjusted EBITDA. Additionally, the completion of a $450 million offering of senior unsecured notes positions Extendicare well for future growth.

Bear case

The recent price decline could indicate market concerns about the sustainability of Extendicare's growth or potential overvaluation, given its high P/E ratio of 28.24. Furthermore, the stock's beta of 1.15 suggests higher volatility compared to the broader market, which could be a risk factor for conservative investors.

Recent Price Action

Extendicare Inc's stock has seen a significant drop in price this week, closing at C$36.40 on Thursday, down 4.43% for the day and 1.69% over the past week. Year-to-date, however, the stock has performed exceptionally well, increasing by 74.10%. This sharp contrast in performance highlights the volatility that can occur in the health care sector.

Advertisement

Company News and Developments

There were no major news announcements from Extendicare this week. However, investors may be reflecting on recent corporate activities, including the completion of a $450 million offering of senior unsecured notes and the ongoing focus on growth in the home health care segment. These developments are crucial as they may influence the company's future performance and investor sentiment.

Technical Picture

From a technical standpoint, Extendicare's stock is currently trading above its 50-day moving average of C$34.95 and significantly above its 200-day moving average of C$26.43, indicating a strong upward trend over the long term. The stock's beta of 1.15 suggests that it is slightly more volatile than the overall market. The recent trading volume was 280,962 shares, which is 1.53 times the 20-day average volume of 363,204 shares, indicating heightened interest in the stock.

Price Action Summary

As of the last close, Extendicare Inc's stock price stands at C$36.40, reflecting a 4.43% decline for the day. This decline comes despite a strong year-to-date performance, prompting a closer examination of market conditions and investor sentiment.

Advertisement

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: July 30, 2026
Last Updated: July 30, 2026

Sponsored links

Advertisement